Source: iQoncept / Shutterstock
Purple Biotech (NASDAQ:PPBT) has recently released their outcomes for the second quarter of 2024.
- In an unexpected turn of events, Purple Biotech’s earnings per share stood at -9 cents, surpassing analysts’ projections of -18 cents.
- During the quarter, the company refrained from disclosing any revenue figures.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/08/ppbt-stock-earnings-purple-biotech-for-q2-of-2024/.
©2024 InvestorPlace Media, LLC
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
